UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

		þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 31, 2005

Commission File No. 001-31552

Smith & Wesson Holding Corporation

Nevada		87-0543688
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

2100 Roosevelt Avenue Springfield, Massachusetts		01104
(Address of principal executive offices)		(Zip Code)

(800) 331-0852
(Registrant’s telephone number, including area code):

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ     No o

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes o     No þ

     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o     No þ

     The registrant had 39,206,647 common shares, par value $0.001, outstanding as of December 1, 2005.

 

 

SMITH & WESSON HOLDING CORPORATION

Quarterly Report on Form 10-Q
For the Quarter Ended October 31, 2005

TABLE OF CONTENTS

PART I		FINANCIAL INFORMATION
Item 1.		Financial Statements
Item 2.		Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3.		Quantitative and Qualitative Disclosures About Market Risk
Item 4.		Controls and Procedures
PART II		OTHER INFORMATION
Item 1.		Legal Proceedings
Item 4.		Submission of Matters to a Vote of Security Holders
Item 6.		Exhibits
Signatures
Exhibit 31.1
Exhibit 31.2
Exhibit 32.1
Exhibit 32.2

PART I: FINANCIAL INFORMATION

Item 1: Financial Statements

SMITH & WESSON HOLDING CORPORATION and Subsidiaries
CONSOLIDATED BALANCE SHEETS
As of:

		October 31, 2005				April 30, 2005
		(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents		$	497,694			$	4,081,475
Accounts receivable, net of allowance for doubtful accounts of $66,522 on October 31, 2005 and $75,000 on April 30, 2005			19,477,616				18,373,713
Inventories			23,413,728				19,892,581
Other current assets			3,607,764				2,388,286
Deferred income taxes			5,560,354				6,119,561
Income tax receivable			263,660				3,701
Total current assets			52,820,816				50,859,317
Property, plant and equipment, net			20,926,999				16,726,361
Intangibles, net			354,603				364,908
Notes receivable			1,007,565				1,029,812
Deferred income taxes			6,478,008				7,806,702
Other assets			4,529,507				5,205,246
		$	86,117,498			$	81,992,346
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable		$	10,605,985			$	12,034,692
Accrued other expenses			3,727,299				3,482,425
Accrued payroll			3,718,139				3,220,730
Accrued taxes other than income			619,737				589,449
Accrued profit sharing			770,694				2,403,019
Accrued workers’ compensation			421,000				536,773
Accrued product liability			2,550,616				2,524,996
Accrued warranty			1,216,584				1,416,092
Deferred revenue			4,836				15,646
Financial instrument liability			1,306,800				—
Current portion of notes payable			6,137,839				1,586,464
Total current liabilities			31,079,529				27,810,286
Notes payable			15,197,862				16,028,424
Other non-current liabilities			7,484,969				11,062,459
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $.001 par value, 20,000,000 shares authorized, no shares issued or outstanding			—				—
Common stock, $.001 par value, 100,000,000 shares authorized, 39,206,647 shares on October 31, 2005 and 31,974,017 shares on April 30, 2005 issued and outstanding			39,207				31,974
Additional paid-in capital			29,740,245				27,744,819
Deferred compensation			(118,338	)			—
Retained earnings (deficit)			2,694,024				(685,616	)
Total stockholders’ equity			32,355,138				27,091,177
		$	86,117,498			$	81,992,346

The accompanying notes are an integral part of these consolidated financial statements.

SMITH & WESSON HOLDING CORPORATION and Subsidiaries
CONSOLIDATED STATEMENTS OF OPERATIONS
AND OTHER COMPREHENSIVE INCOME
(UNAUDITED)

		Three Months Ended								Six Months Ended
						Restated								Restated
						(Note 12)								(Note 12)
		October 31, 2005				October 31, 2004				October 31, 2005				October 31, 2004
Net product and services sales		$	35,536,967			$	29,078,039			$	67,386,690			$	56,846,914
License revenue			482,213				526,018				1,282,190				922,768
Cost of products and services sold			25,469,628				17,210,562				48,444,544				35,982,629
Cost of license revenue			4,750				4,663				80,645				33,821
Gross profit			10,544,802				12,388,832				20,143,691				21,753,232
Operating expenses:
Research and development, net			102,026				38,184				141,866				75,323
Selling and marketing			3,770,483				3,160,186				7,720,760				6,021,436
General and administrative			5,434,206				4,901,362				9,314,047				8,579,016
Environmental (credits)			—				—				(3,087,810	)			—
Total operating expenses			9,306,715				8,099,732				14,088,863				14,675,775
Income from operations			1,238,087				4,289,100				6,054,828				7,077,457
Other income (expense):
Other income (expense)			178,786				(107,687	)			221,677				207,306
Interest income			39,651				101,049				58,155				183,299
Interest expense			(362,282	)			(819,261	)			(911,619	)			(1,654,638	)
			(143,845	)			(825,899	)			(631,787	)			(1,264,033	)
Income before income taxes			1,094,242				3,463,201				5,423,041				5,813,424
Income tax expense			401,865				1,356,791				2,043,401				2,240,015
Net income		$	692,377			$	2,106,410			$	3,379,640			$	3,573,409
Weighted average number of common and common equivalent shares outstanding, basic			35,858,826				31,279,739				33,988,252				31,144,761
Net income per share, basic		$	0.02			$	0.07			$	0.10			$	0.11
Weighted average number of common and common equivalent shares outstanding, diluted			39,662,462				36,329,973				39,290,302				36,278,796
Net income per share, diluted		$	0.02			$	0.06			$	0.09			$	0.10

The accompanying notes are an integral part of these consolidated financial statements.

SMITH & WESSON HOLDING CORPORATION and Subsidiaries
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
(UNAUDITED)
For the Six Months Ended October 31, 2005

																		Additional				Retained								Total
		Preferred Stock								Common Stock								Paid-in				Earnings				Deferred				Stockholders'
		Shares				Amount				Shares				Amount				Capital				(Deficit)				Compensation				Equity
Balance at April 30, 2005			—			$	—				31,974,017			$	31,974			$	27,744,819			$	(685,616	)		$	—			$	27,091,177
Exercise of warrants											829,700				830				915,602												916,432
Repurchase of common stock warrants from former employees											—				—				(23,950,701	)											(23,950,701	)
Exercise of employee stock options											314,458				315				342,828												343,143
Shares issued under Employee Stock Purchase Plan											88,472				88				188,143												188,231
Stock option expense																			854,511												854,511
Net proceeds from sale of common stock and common stock warrants											6,000,000				6,000				23,230,657												23,236,657
FAS123(R) tax benefit																			296,048												296,048
Issuance of non-employee stock options																			118,338								(118,338	)			—
Net income for the six months ended October 31, 2005																							3,379,640								3,379,640
Balance at October 31, 2005			—			$	—				39,206,647			$	39,207			$	29,740,245			$	2,694,024			$	(118,338	)		$	32,355,138

The accompanying notes are an integral part of these consolidated financial statements.

SMITH & WESSON HOLDING CORPORATION and Subsidiaries
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
For the Six Months Ended:

						Restated
						(Note 12)
		October 31, 2005				October 31, 2004
Cash flows from operating activities:
Net income		$	3,379,640			$	3,573,409
Adjustments to reconcile net income to cash (used for) provided by operating activities:
Amortization and depreciation			2,052,951				1,095,054
Gain on disposal of IdentiKit			—				(450,515	)
Gain on disposal of assets			(10,780	)			(7,405	)
Write-off of patents			—				39,741
Deferred taxes			1,887,901				2,112,714
Provision for losses on accounts receivable			9,800				6,500
Provision for excess and obsolete inventory			330,507				385,713
Valuation adjustment of derivative financial instruments			118,800				—
Stock option expense			854,511				210,303
Changes in operating assets and liabilities
(Increase) decrease in assets:
Accounts receivable			(1,113,703	)			5,315,417
Inventories			(3,851,654	)			(1,879,842	)
Other current assets			(1,219,478	)			(2,887,847	)
Income tax receivable			3,701				(318	)
Note receivable			22,247				20,955
Increase (decrease) in liabilities:
Accounts payable			(1,428,707	)			(1,028,872	)
Accrued payroll			497,409				(904,818	)
Accrued profit sharing			(1,632,325	)			(725,696	)
Accrued taxes other than income			30,288				(6,390	)
Accrued other expenses			45,366				(158,670	)
Accrued income taxes			32,388				—
Accrued workers’ compensation			(115,773	)			75,000
Accrued product liability			25,620				(314,352	)
Other non-current liabilities			(3,577,490	)			(3,513,321	)
Deferred revenue			(10,810	)			(256,887	)
Net cash (used for) provided by operating activities			(3,669,591	)			699,873
Cash flows from investing activities:
Proceeds from sale of marketable securities			—				1,518,493
Reductions in collateralized cash deposits			—				323,531
Payments to acquire patents			(2,489	)			(17,306	)
Proceeds from sale of IdentiKit			—				300,000
Proceeds from sale of property and equipment			35,901				7,465
Payments to acquire property and equipment			(6,010,360	)			(3,903,186	)
Net cash (used for) investing activities			(5,976,948	)			(1,771,003	)
Cash flows from financing activities:
Other assets			420,183				1,330,090
Payment on notes payable, Tomkins			—				(1,417,782	)
Proceeds from loans and notes payable			4,500,000				—
Proceeds from exercise of options to acquire common stock including employee stock purchase plan			531,374				476,184
Proceeds from sale of common stock and common warrants			24,424,657				123,307
Repurchase of warrants			(23,950,701	)			—
Proceeds from exercise of warrants to acquire common stock			916,432				—
Payments on loans and notes payable			(779,187	)			(559,914	)
Net cash provided by (used for) financing activities			6,062,758				(48,115	)
Net decrease in cash and cash equivalents			(3,583,781	)			(1,119,245	)
Cash and cash equivalents, beginning of year			4,081,475				5,510,663
Cash and cash equivalents, end of period		$	497,694			$	4,391,418

The accompanying notes are an integral part of these consolidated financial statements.

SMITH & WESSON HOLDING CORPORATION and Subsidiaries
CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended October 31, 2005 and 2004

(1) Basis of Presentation:

     The consolidated balance sheet as of October 31, 2005, the consolidated statements of operations and other comprehensive income for the three and six months ended October 31, 2005 and 2004, the consolidated statements of changes in stockholders’ equity for the six months ended October 31, 2005, and the consolidated statement of cash flows for the six months ended October 31, 2005 and 2004 have been prepared by us, without audit. The quarter end for our wholly-owned subsidiary, Smith & Wesson., was October 30, 2005, a one-day variance to our reported fiscal quarter end of October 31, 2005. This variance does not create any material difference in the financial statements as presented. In our opinion, all adjustments, which include only normal recurring adjustments necessary to fairly present the financial position, results of operations, changes in stockholders’ equity, and cash flows at October 31, 2005 and for the periods presented have been included. All significant intercompany transactions have been eliminated. The balance sheet as of April 30, 2005 has been derived from our audited financial statements.

     Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted. These consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in our company’s Annual Report on Form 10-K for the year ended April 30, 2005. The results of operations for the six months ended October 31, 2005 may not be indicative of the results that may be expected for the year ended April 30, 2006 or any other period.

(2) Organization:

Organization

     We were incorporated on June 17, 1991 in the state of Nevada.

     Our wholly-owned subsidiary, Smith & Wesson Corp. was incorporated under the laws of the state of Delaware on January 13, 1987. Smith & Wesson Corp. and its predecessors have been in business since 1852. Since its formation, Smith & Wesson Corp. has undergone several ownership changes. On June 9, 1987, Tomkins Corporation (“Tomkins”), a company organized under the laws of the state of Delaware that is a subsidiary of U.K.-based Tomkins PLC, acquired Smith & Wesson Corp. from Lear Siegler.

     On May 11, 2001, we purchased all of the outstanding stock of Smith & Wesson Corp. from Tomkins for $15,000,000. At a special meeting of stockholders held on February 14, 2002, our stockholders approved a change of our company’s name to Smith & Wesson Holding Corporation.

(3) Acquisition of Smith & Wesson Corp.:

The Acquisition

     Pursuant to a Stock Purchase Agreement dated as of May 11, 2001 between Tomkins and us, we acquired all of the issued and outstanding stock of Smith & Wesson Corp. As a result of the acquisition, Smith & Wesson Corp. became our wholly owned subsidiary. We paid $15,000,000 in exchange for all of the issued and outstanding shares of Smith & Wesson Corp. as follows:

     · $5 million, which was paid at closing in cash.

     · $10 million due on or before May 11, 2002 pursuant to the terms of an unsecured promissory note issued by us to Tomkins providing for interest at a rate of 9% per year. During March 2002, we obtained a bank loan and paid off the entire loan balance.

     · The acquisition agreement required us to guarantee the obligations of Smith & Wesson Corp. to Tomkins under a promissory note issued on April 30, 1997 by Smith & Wesson Corp. to Tomkins (the “Tomkins Note”). The Tomkins Note originally was in the amount of $73,830,000, was due on April 30, 2004, and bore interest at the rate of 9% per annum. Prior to the

acquisition, Tomkins contributed $23,830,000 of the Tomkins note to the capital of Smith & Wesson Corp., leaving a balance of $50,000,000. Immediately subsequent to the acquisition, we paid $20,000,000 on the Tomkins note. We repaid an additional $2,000,000 of the outstanding principal balance in April 2003 and another $1,000,000 in October 2003. The outstanding principal balance and interest payable on the Tomkins note as of January 11, 2005 was $25,095,322 with an interest rate of 9% per annum. During January 2005, we obtained a bank loan and paid off the entire note balance.

     · A receivable of $464,500 due from Tomkins to us, which has been collected.

(4) Debt:

     In January 2005, we completed the refinancing of our existing debt utilizing our receivables, inventory and property, plant and equipment as collateral. The financing was obtained through TD BankNorth, with which we had previous loans. As a result of our refinancing, we were able to repay the Tomkins Note, which had an interest rate of 9% per year and restrictive covenants, along with the previously existing loans with TD BankNorth. We used the cash that was collateral for our existing line of credit with BankNorth toward the repayment of the Tomkins Note.

     The new credit facility consists of the following:

     (1) A revolving line of credit in an amount up to a maximum amount of the lesser of (a) $17 million; or (b) (i) 85% of the net amount of our eligible receivables as defined; (ii) plus the lesser of $6 million or 70% of eligible raw materials inventory; plus (iii) 60% of eligible finished goods inventory; and (iv) 40% of Eligible Finished Parts Inventory. The revolving line of credit bears interest at a variable rate equal to prime or LIBOR plus 250 basis points (with the 250 basis point LIBOR spread being reduced if we meet certain targets with respect to our maximum leverage). The amount available under this line of credit is reduced by any outstanding letters of credit, an ACH holdback of $420,000 and 15% of any outstanding forward hedging contracts (Item 3). There was $4.5 million outstanding under this line of credit as of October 31, 2005 bearing interest at a rate of 6.75% per annum.

     (2) A seven-year, $12.1 million term loan bearing interest at a rate of 6.23% per annum. The monthly payment is $178,671, with the final payment due on January 11, 2012.

     (3) A ten-year, $5.9 million term loan bearing interest at a rate of 6.85% per annum. The monthly payment is $45,525 through December 11, 2014 with a balloon payment due on January 11, 2015 of $3,975,611.

     (4) A $5 million credit arrangement for capital expenditures, which will bear interest at a variable rate until April 30, 2006 equal to either prime or LIBOR plus 250 basis points (with the 250 basis point LIBOR spread being reduced if we meet certain targets with respect to our maximum leverage), and then either a variable rate equal to LIBOR plus 250 basis points (with the 250 basis point LIBOR spread being reduced if we meet certain targets with respect to our maximum leverage), or a fixed rate equal to the Federal Home Loan Bank of Boston Rate as of April 30, 2006 plus 200 basis points, in each case with the applicable rate selected by us. The aggregate availability of this facility will cease on April 30, 2006, at which time any unpaid outstanding principal balance and interest will become due and payable in monthly installments over a period of seven years. There were no amounts outstanding as of October 31, 2005.

     We are in full compliance with all bank covenants as of October 31, 2005.

(5) Inventory:

     A summary, stated at lower of first in, first out cost or market, is as follows:

		October 31, 2005				April 30, 2005
Finished goods		$	9,008,081			$	7,456,857
Finished parts			9,660,014				8,973,434
Work in process			2,953,201				1,917,912
Raw Material			1,792,432				1,544,378
		$	23,413,728			$	19,892,581

(6) Advertising Costs:

     We expense advertising costs, primarily consisting of magazine advertisements and printed materials, as incurred. For the six months ended October 31, 2005 and 2004, advertising expense was approximately $3,482,000 and $2,345,000, respectively.

(7) Warranty Reserve:

     We generally provide a lifetime warranty to the “original” purchaser of our firearms products. We provide for estimated warranty obligations in the period in which we recognize the related revenue. We quantify and record an estimate for warranty related costs based on our actual historical claims experience and current repair costs. We make adjustments to accruals as warranty claim data and historical experience warrant. Should we experience actual claims and repair costs that are higher than the estimated claims and repair costs used to calculate the provision, our operating results for the period or periods in which such returns or additional costs materialize would be adversely impacted. Warranty expense for the six months ended October 31, 2005 and 2004 was $434,216 and $695,105, respectively.

     The change in accrued warranties for the six months ended October 31, 2005 and the fiscal year ended April 30, 2005 was as follows:

		Six months ended				Year ended
		October 31, 2005				April 30, 2005
Beginning Balance		$	1,639,545			$	1,742,917
Provision for warranties			434,216				1,539,400
Warranty claims			(646,640	)			(1,642,772	)
Ending Balance		$	1,427,121			$	1,639,545

(8) Self-Insurance Reserves:

     As of October 31, 2005 and April 30, 2005, we had reserves for workers’ compensation, product liability, and medical/dental costs totaling $10,022,380 and $10,658,339, respectively, of which $6,180,533 and $6,723,647, respectively, have been classified as non-current and included in other non-current liabilities, and the remaining amounts of $3,841,847 and $3,934,692, respectively, have been included in current liabilities on the accompanying consolidated balance sheets. While we believe these reserves to be adequate, there exists a possibility that the ultimate liabilities will exceed such estimates. Amounts charged (credited) to expense were $1,129,894 and ($1,703,205) for the six months ended October 31, 2005 and 2004, respectively.

     It is our policy to provide an estimate for loss as a result of expected adverse findings or legal settlements when we believe such losses are probable and are reasonably estimable. It is also our policy to accrue for reasonable estimable legal costs associated with defending such litigation. While such estimates involve a range of possible costs, we determine, in consultation with litigation counsel, the most likely cost within such range on a case-by-case basis. At October 31, 2005 and April 30, 2005, we had product liability reserves of approximately $7.6 million and $8.0 million, respectively, consisting entirely of expected legal defense costs. In addition, we had recorded receivables from insurance carriers related to these liabilities of approximately $5.4 million, of which, approximately $4.2 million, has been classified as other assets and the remaining $1.2 million has been classified as other current assets.

(9) Commitments and Contingencies:

Litigation

     We, together with other firearms manufacturers and certain related organizations, are a co-defendant in various legal proceedings involving product liability claims and are aware of other product liability claims, including allegations of defective product design, manufacturing, negligent marketing, and/or distribution of firearms leading to personal injury, including wrongful death. The lawsuits and claims are based principally on the theory of “strict liability,” but also may be based on negligence, breach of warranty, and other legal theories. In many of the lawsuits, punitive damages, as well as compensatory damages, are demanded. Aggregate claimed amounts currently exceed product liability accruals and, if applicable, insurance coverage. We believe that, in every case, the various allegations as described above are unfounded, and, in addition, that any accident and any results from them were due to negligence or misuse of the firearm by the claimant or a third party and that there should be no recovery against us.

     In addition, we are a co-defendant in various legal proceedings brought by certain cities, municipalities, and counties against numerous firearms manufacturers, distributors, and dealers seeking to recover damages allegedly arising out of the misuse of firearms by third parties in shootings. The complaints by municipalities seek damages, among other things, for the costs of medical care, police and emergency services, public health services, and the maintenance of courts, prisons, and other services. In certain instances, the plaintiffs seek to recover for decreases in property values and loss of business within the city due to increased criminal violence. In addition, nuisance abatement and/or injunctive relief is sought to change the design, manufacture, marketing, and distribution practices of the various defendants. These suits allege, among other claims, strict liability or negligence in the design of products, public nuisance, negligent entrustment, negligent distribution, deceptive or fraudulent advertising, violation of consumer protection statutes, and conspiracy or concert of action theories. We believe that, in every case, the various allegations as described above are unfounded, and, in addition, that any accident and any results from them were due to negligence or misuse of the firearm by a third party and that there should be no recovery against us.

     We monitor the status of known claims and the product liability accrual, which includes amounts for defense costs for asserted and unasserted claims. While it is difficult to forecast the outcome of these claims, we believe, after consultation with litigation counsel, that it is uncertain whether the outcome of these claims will have a material adverse effect on our financial position, results of operations, or cash flows. We believe that we have provided adequate reserves for defense costs. We do not anticipate material adverse judgments and intend to vigorously defend ourselves.

     At this time, an estimated range of reasonably possible additional losses, as that term is defined in Statement of Financial Accounting Standard (SFAS) No. 5, relating to unfavorable outcomes cannot be made. However, in the product liability cases in which a dollar amount of damages is claimed, the amount of damages claimed, which totaled $611,000 at October 31, 2005, is set forth as an indication of possible maximum liability that we might be required to incur in these cases (regardless of the likelihood or reasonable probability of any or all of this amount being awarded to claimants) as a result of adverse judgments that are sustained on appeal.

     In the quarter ended October 31, 2005, we incurred no defense costs relative to product liability and municipal litigation. During this period, we paid no settlement fees relative to product liability cases. As a result of our regular review of our product liability claims, no reserve adjustments were needed.

     We have recorded the liability for defense costs at a level before reimbursement from insurance carriers. We have also recorded the amount due as reimbursement under existing policies from the insurance carriers as a receivable shown in other current assets and other assets.

     On October 26, 2005, President George W. Bush signed into law the Protection of Lawful Commerce in Arms Act. The legislation is designed to prohibit civil liability actions from being brought or continued against manufacturers, distributors, dealers, or importers of firearms or ammunition for damages, injunctions, or other relief resulting from the misuse of their products by others. The legislation, by its terms, would result in the dismissal against us and preclude similar cases in the future. The legislation does not preclude traditional product liability actions. There have been constitutional and other challenges to the legislation in some of the pending cases. We cannot predict whether judges in existing proceedings will dismiss cases currently pending before them. No adjustments to municipal litigation reserves have been made as a result of the passage of this law.

Securities and Exchange Commission (“SEC”) Investigation

     The SEC is conducting an investigation to determine whether there have been violations of the federal securities laws in connection with matters relating to the restatement of our consolidated financial statements for fiscal 2002 and the first three quarters of fiscal 2003. We continue to be in discussions with the SEC and intend to continue to cooperate fully with the SEC. There has been no change in the status of this investigation during the quarter ended October 31, 2005.

Environmental Remediation

     We are subject to numerous federal, state, and local laws that regulate the discharge of materials into, or otherwise relate to the protection of, the environment. These laws have required, and are expected to continue to require, us to make significant expenditures of both a capital and expense nature. Several of the more significant federal laws applicable to our operations include the Clean Air Act, the Clean Water Act, the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”) and the Solid Waste Disposal Act, as amended by the Resource Conservation and Recovery Act.

     We have programs and personnel monitor compliance with various federal, state, and local environmental regulations. In the normal course of our manufacturing operations, we are subject to occasional governmental proceedings and orders pertaining to waste disposal, air emissions, and water discharges into the environment. We fund our environmental costs through cash flows from operating revenue and expect to do so in the future. We believe that we are in compliance with applicable environmental regulations in all material respects.

     We are required to remediate hazardous waste at our facilities. Currently, we own designated sites in Springfield, Massachusetts and are subject to five release areas that are the focus of remediation projects as part of the Massachusetts Contingency Plan, or MCP. Three of these sites are contained on property sold to the Springfield Redevelopment Authority or SRA. The MCP provides a structured environment for the voluntary remediation of regulated releases. We may be required to remove hazardous waste or remediate the alleged effects of hazardous substances on the environment associated with past disposal practices at sites not owned by us. We have received notice that we are a potentially responsible party from the Environmental Protection Agency, or EPA, and/or individual states under CERCLA or a state equivalent at one site.

     As of October 31, 2005, we had reserves of approximately $648,000 ($567,000 as non-current) for remediation of the remaining sites. The time frame for payment of such remediation for the remaining sites is currently indeterminable thus precluding any present value calculation. Our estimates of these costs are based upon presently enacted laws and regulations, currently available facts, experience in remediation efforts, existing technology, and the ability of other potentially responsible parties or contractually liable parties to pay the allocated portions of any environmental obligations. When the available information is sufficient to estimate the amount of liability, that estimate has been used; when the information is only sufficient to establish a range of probable liability and no point within the range is more likely than any other, the lower end of the range has been used. We do not have insurance coverage for our environmental remediation costs. We have not recognized any gains from probable recoveries or other gain contingencies. The environmental reserve was calculated using undiscounted amounts based on independent environmental remediation reports obtained.

     On February 25, 2003, we sold approximately 85 acres of company-owned property in the city of Springfield, Massachusetts to the SRA for $1.75 million, resulting in a net gain of $1.7 million. The terms of the sale included a cash payment of $750,000 at the closing and a promissory note for the remaining $1.0 million. The note is collateralized by a mortgage on the sold property. This note is due in 2022 and accrues interest at a fixed rate of 6.0% per annum.

     This property is excess land adjacent to our manufacturing and office facility. The 85 acres includes three of our five previously disclosed release areas that have identified soil and groundwater contamination under the MCP, specifically the South Field, West Field, and Fire Pond. This property was acquired by SRA as a defined “Brownfield” under the CERCLA. We believe that the SRA plans to create a light industrial and other commercial use development park on the property. SRA, with the support of the city of Springfield, has received governmental “Brownfield” grants or loans to facilitate the remediation and development of the property. The remediation of the property was completed during the quarter ended July 31, 2005. Consequently, we have released the reserve related to the property. This adjustment totaled approximately $3.1 million and is included as a credit to environmental expense within operating expenses for the six months ended October 31, 2005. Based upon previously identified specific facts and circumstances, we may revise the environmental reserve in the future. Any revision could have a significant impact on us in the period in which an adjustment is made.

     Based on information known to us, we do not expect current environmental regulations or environmental proceedings and claims to have a material adverse effect on our financial position, results of operations, or cash flows. However, it is not possible to predict with certainty the impact on us of future environmental compliance requirements or of the cost of resolution of future environmental proceedings and claims, in part because the scope of the remedies that may be required is not certain, liability under federal environmental laws is joint and several in nature, and environmental laws and regulations are subject to modification and changes in interpretation. There can be no assurance that additional or changing environmental regulation will not become more burdensome in the future and that any such development would not have a material adverse effect on us.

Contracts

     Employment Agreements — We have entered into employment agreements with certain officers and managers to retain their services in the ordinary course of business.

Other Agreements — We have distribution agreements with third parties in the ordinary course of business. (10) Stockholders’ Equity:

Common Stock

     During the six months ended October 31, 2005 and 2004, options or warrants were exercised and common stock issued as follows:

(a) During the six months ended October 31, 2005, we issued 314,458 shares of common stock having a market value of $1,374,653 to current and former employees upon the exercise of options granted to them while employees of our company. The purchase price of these shares was $343,143.

(b) In October 2005, we issued 88,472 shares of common stock in connection with our Employee Stock Purchase Plan (“ESPP”) having a purchase price of $188,231.

(c) In September 2005, we issued 800,000 shares of common stock having a market value of $4,248,000 to former employees upon the exercise of warrants granted to them while employees of the company. The purchase price of these shares was $712,000.

(d) In May 2005, we issued 29,700 shares of common stock having a market value of $89,038 to a former employee upon the exercise of warrants granted to him while an employee of our company. The purchase price of these shares was $26,433.

(e) During the six months ended October 31, 2004, we issued 456,583 shares of common stock having a market value of $752,787 to former employees upon the exercise of options granted to them while employees of our company. The purchase price of these shares was $476,182.

     (f) In October 2004, we issued 106,811 shares of common stock in connection with our ESPP having a purchase price of $123,307.

     On September 12, 2005, we sold 6,000,000 shares of our common stock and warrants to purchase an additional 1,200,000 shares of our common stock in a private placement transaction. We received gross proceeds of approximately $26,160,000 cash from the sale of the common shares and warrants. We incurred issuance costs of $2,119,343, including a warrant to acquire 120,000 common shares, issued to the placement agent, having a fair value of $384,000. The net proceeds were allocated among the common stock and the warrants sold. In the accompanying balance sheet the 1,200,000 warrants have been classified as liabilities at their issue date at their initial fair value of $804,000 and the residual proceeds from the offering have been attributed to the common stock. The 120,000 warrants issued to the placement agent have also been reported as liabilities at their fair value. During the quarter ended October 31, 2005, the warrant liabilities were remeasured and the change in fair value of $118,800 has been reflected in the accompanying income statement.

     We also concurrently entered into an agreement with three of our Board members allowing us to purchase 1,200,000 shares of common stock from them at $5.33 per share, at the sole option of the company, in the event that the 1,200,000 warrants issued on September 12, 2005 are exercised.

     Earnings per share

     The following table provides a reconciliation of the income amounts and shares used to determine basic and diluted earnings per share for the three months ended October 31, 2005 and 2004.

		For the three months ended												For the three months ended
		October 31, 2005												October 31, 2004 (Restated-Note 12)
		Net												Net
		Income												Income
		Available to												Available to
		Common								Per Share				Common								Per Share
		Shareholders				Shares				Amount				Shareholders				Shares				Amount
Basic earnings per share		$	692,377				35,858,826			$	0.02			$	2,106,410				31,279,739			$	0.07
Valuation adjustment of derivative financial instruments, net of tax			74,012								0.00				—								0.00
Effect of dilutive stock options and warrants			—				3,803,636				(0.00	)			—				5,050,234				(0.01	)
Diluted earnings per share		$	766,389				39,662,462			$	0.02			$	2,106,410				36,329,973			$	0.06

     Options and warrants to purchase 2,035,000 and 378,633 shares of our common stock and warrants were excluded in the quarters ended October 31, 2005 and 2004, respectively, as the effect would be antidilutive. Included in the 2,035,000 shares excluded were 1,320,000 warrants related to the Private Placement which were anti-dilutive.

     The following table provides a reconciliation of the income amounts and shares used to determine basic and diluted earnings per share for the six months ended October 31, 2005 and 2004.

		For the six months ended												For the six months ended
		October 31, 2005												October 31, 2004 (Restated-Note 12)
		Net												Net
		Income												Income
		Available to												Available to
		Common								Per Share				Common								Per Share
		Shareholders				Shares				Amount				Shareholders				Shares				Amount
Basic earnings per share		$	3,379,640				33,988,252			$	0.10			$	3,573,409				31,144,761			$	0.11
Valuation adjustment of derivative financial instruments, net of tax			74,012								0.00				—								0.00
Effect of dilutive stock options and warrants			—				5,302,050				(0.01	)			—				5,134,035				(0.01	)
Diluted earnings per share		$	3,453,652				39,290,302			$	0.09			$	3,573,409				36,278,796			$	0.10

     Options and warrants to purchase 1,435,000 and 253,633 shares of our common stock were excluded in the six months ended October 31, 2005 and 2004, respectively, as the effect would be antidilutive. Included in the 1,435,000 shares excluded were 1,320,000 warrants related to the Private Placement which were anti-dilutive.

Stock Warrants

     In fiscal 2002, we issued warrants related to the financing of debt used for the acquisition of Smith & Wesson Corp., as incentive bonuses to employees and directors, and as compensation to outside consultants.

     In consideration for past services to our company, including services rendered in connection with the acquisition of Smith & Wesson Corp., we issued a common stock purchase warrant, dated May 11, 2001 to Mitchell Saltz, formerly Chief Executive Officer and currently a director of our company (the “Saltz Warrant”). The Saltz Warrant, which contained a cashless exercise provision, entitled Mr. Saltz to purchase up to 5,000,000 shares of common stock at an exercise price of $0.89 per share, subject to adjustment as set forth therein, at any time from the date of issuance until five years from the date of issuance.

     In consideration for past services to our company, including services rendered in connection with the acquisition of Smith & Wesson Corp., we issued a common stock purchase warrant, dated May 11, 2001 to Robert L. Scott, a former officer and current director of our company (the “Scott Warrant”). The Scott Warrant, which contained a cashless exercise provision, entitled Mr. Scott to purchase up to 5,000,000 shares of common stock at an exercise price of $0.89 per share, subject to adjustment as set forth therein, at any time from the date of issuance until five years from the date of issuance.

     During the year ended April 30, 2005, Mr Scott exercised 311,250 warrants on a cashless basis resulting in 200,000 common shares issued. As a result, at year end 2005, the unexercised Salz and Scott warrants were 9,688,750 as shown in the table below. Subsequently, in May 2005, Mr. Scott determined to exercise these warrants on a gross basis and paid the $0.89 cash exercise price for the 200,000 shares received. As a result, Mr. Scott exercised 200,000 warrants on a gross exercise basis rather than 341,250 warrants on a cashless exercise basis. As a result, the Company reinstated 111,250 warrants as unexercised warrants in May 2005.

     During May 2005, we amended the Saltz and Scott warrants to eliminate the cashless exercise feature which permitted the warrants to be net share settled. The effect of this modification was determined not to cause incremental compensation cost.

     During the six months ended October 31, 2005, Mr. Saltz exercised 500,000 warrants and Mr. Scott exercised 329,700 warrants on a gross basis resulting in 8,970,300 unexercised warrants at September 12, 2005.

     On September 12, 2005, we entered into an termination agreement in which Messrs. Saltz and Scott tendered their unexercised warrants to purchase 8,970,300 shares to the Company in exchange for a cash payment of $2.67 per share. The Company’s purchase of these warrants on September 12, 2005 did not result in additional compensation expense.

     The Saltz and Scott warrants were initially valued at $0.89 per share, or $7,983,567. See Note 12.

     The following outlines the activity related to these warrants for the periods indicated:

		For the six months ended October 31,
		2005								2004
						Weighted-								Weighted-
						Average								Average
		Shares				Exercise Price				Shares				Exercise Price
Warrants outstanding, beginning of the period			9,688,750			$	0.89				10,000,000			$	0.89
Warrants sold to investors and issued to a placement agent during the period			1,320,000			$	5.24				—
Reinstatement of warrants Mr. Scott previously exercised on a cashless basis			111,250			$	0.89				—			$	0.89
Saltz and Scott exercised during the period			(829,700	)		$	0.89				—			$	0.89
Saltz and Scott repurchased during the period			(8,970,300	)		$	0.89				—
Warrants outstanding, end of the period			1,320,000			$	5.24				10,000,000			$	0.89
Shares exercisable, end of the period			1,320,000			$	5.24				10,000,000			$	0.89
Weighted average remaining life		309 days								1.8 years

Employee Stock Option and Employee Stock Purchase Plans

     We have two Employee Stock Option Plans (“the SOPs”): the 2001 Stock Option Plan and the 2004 Incentive Compensation Plan. New grants were not made under the 2001 Stock Option Plan following the approval of the 2004 Incentive Compensation Plan at our 2004 annual meeting of stockholders. All new grants covering all participants will be issued under the 2004 Incentive Compensation Plan. The 2004 Incentive Compensation Plan authorizes the issuance of the lesser of (1) 15% of the shares of our common stock outstanding from time to time or (2) 10,000,000 shares of our common stock, and such shares are available for issuance pursuant to options granted to acquire common stock, the direct granting of restricted common stock or deferred stock, the granting of stock appreciation rights, or the granting of dividend equivalents. The Board of Directors or a committee established by the board administers the SOPs, selects recipients to whom options are granted, and determines the number of grants to be awarded. Options granted under the SOPs are exercisable at a price determined by the board or committee at the time of grant, but in no event at a price less than fair market value. Grants of options may be made to employees and directors without regard to any performance measures. All options issued pursuant to the SOPs are nontransferable and subject to forfeiture. Unless terminated

earlier by the Board of Directors, the 2004 Incentive Compensation Plan will terminate at such time as no shares of common stock remain available for issuance under the plan and our company has no further rights or obligations with respect to outstanding awards under the plan. Unless otherwise specified by the Board of Directors or board committee in the resolution authorizing such option, the date of grant of an option is deemed to be the date upon which the Board of Directors or board committee authorizes the granting of such option. Generally, options vest over a period of three years. During the six months ended October 31, 2005 and 2004, we granted options to purchase 760,000 options and 215,000 shares, respectively. The number and weighted average exercise prices of options granted under the SOPs and an employee grant outside the SOPs for the six months ended October 31, 2005 and 2004 were as follows:

		For the six months ended October 31,
		2005								2004
						Weighted-								Weighted-
						Average								Average
		Shares				Exercise Price				Shares				Exercise Price
Options outstanding, beginning of the period			2,467,125			$	1.30				2,389,092			$	1.17
Granted during the period			760,000			$	4.58				215,000			$	1.51
Exercised during the period			(314,458	)		$	1.09				(456,583	)		$	1.04
Cancelled/forfeited during the period			—				—				(263,917	)		$	1.55
Options outstanding, end of the period			2,912,667			$	2.18				1,883,592			$	1.19
Shares exercisable, end of the period			1,217,248			$	1.14				1,429,423			$	1.06

     A summary of stock options outstanding and exercisable at October 31, 2005 follows:

		Outstanding												Exercisable
		Number				Weighted Average				Weighted				Number				Weighted
		Outstanding				Remaining				Average				Exercisable at				Average
		at October 31				Contractual Life				Exercise Price				October 31				Exercise Price
Range of Exercise Prices
$0.81 — $1.47			1,470,000			7.04 years				$	1.13				873,335			$	0.89
$1.48 — $4.46			1,302,667			9.17 years				$	3.02				337,249			$	1.69
$5.29 — $5.83			140,000			9.85 years				$	5.43				6,664			$	5.31
$0.81 — $5.83			2,912,667			8.31 years				$	2.18				1,217,248			$	1.14

     We also have an Employee Stock Purchase Plan (“the ESPP”), which authorizes the sale of up to 10,000,000 shares of our common stock to employees. The ESPP commenced on June 24, 2002 and continues in effect for a term of 10 years unless sooner terminated. The ESPP was implemented by a series of offering periods of two year duration, with four six-month purchase periods in the offering period. The plan was amended in September 2004 such that future offering periods, commencing with the October 1, 2004 offering period, will be six months, consistent with the six-month purchase period. The purchase price is 85% of the fair market value of our common stock on the offering date or on the purchase date, whichever is lower. A participant may elect to have payroll deductions made on each payday during the offering period in an amount not less than 1% and not more than 20% (or such greater percentage as the board may establish from time to time before an offering date) of such participant’s compensation on each payday during the offering period. The last day of each offering period will be the purchase date for such offering period. An offering period commencing on April 1 ends on the next September 30. An offering period commencing on October 1 ends on the next March 31. The Board of Directors has the power to change the duration and/or the frequency of offering and purchase periods with respect to future offerings and purchases without stockholder approval if such change is announced at least five days prior to the scheduled beginning of the first offering period to be affected. The maximum number of shares an employee may purchase during each purchase period is 12,500 shares. All options and rights to participate in the ESPP are nontransferable and subject to forfeiture in accordance with the ESPP guidelines. In the event of certain corporate transactions, each option outstanding under the ESPP will be assumed or an equivalent option will be substituted by the successor corporation or a parent or subsidiary of such successor corporation. During the six months ended October 31, 2005 and 2004, 88,472 and 106,811 shares were purchased under the ESPP, respectively.

     During the year ended April 30, 2005, we adopted Statement of Financial Accounting Standard (“SFAS”___No. 123(R), “Share-Based Payments,” which requires the measurement of the cost of employee services received in exchange for an award of an equity instrument based on the grant-date fair value of the award. We elected the modified retrospective application method in adopting SFAS 123(R), which resulted in the restatement of prior period amounts in order to present comparable compensation data (Note 12). In accordance with SFAS 123(R), we have calculated the fair value of our stock options and warrants issued to employees using the Black-Scholes method at the time the options and warrants were granted. That amount is then amortized over the vesting period of the option or warrant. As noted above, warrants issued to employees (Saltz and Scott) in May, 2001 were immediately vested. With our ESPP, a fair value is determined at the beginning of the purchase period and amortized over the term of the

offering period. The following assumptions were used in valuing our options and ESPP under SFAS 123(R), granted during the sixth month periods ended October 31, 2005 and 2004, there were no warrants granted to employees in these periods:

		Six months ended
		October 31,
		2005				2004
Stock option grants:
Risk-free interest rate			4.19	%			4.34	%
Expected life		9.2 years				9.1 years
Expected volatility			73.4	%			79.7	%
Dividend yield			0	%			0	%
Employee Stock Purchase Plan:
Risk-free interest rate			3.42	%			1.75	%
Expected life		6 months				1.3 years
Expected volatility			59.4	%			75.3	%
Dividend yield			0	%			0	%

     We estimate expected volatility using past historical volatility for the expected term. The fair value of each stock option or ESPP purchase was estimated on the date of the grant using the Black-Scholes option pricing model. The weighted-average fair value of stock options granted during the three months ended October 31, 2005 and 2004 was $3.54 and $1.22, respectively. The weighted-average fair value of ESPP shares granted during the three months ended October 31, 2005 and 2004 was $1.12 and $0.71, respectively. The total stock-based compensation expense was $854,511 and $210,303 for the six months ended October 31, 2005 and 2004, respectively. Stock-based compensation expense is included in general and administrative expenses.

(11) Private Placement Offering

     On September 12, 2005 we completed the sale of an aggregate of 6,000,000 shares of our common stock (the “Shares”) and warrants to purchase an additional 1,200,000 shares of its common stock (the “Warrants”). The sale was made to institutional investors in reliance upon the exemption from registration requirements under Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D under such Act (the “Private Placement”). We received gross proceeds of $28,020,000 cash from the sale of theses Securities. We agreed to promptly file a registration statement with the Securities and Exchange Commission to register the Shares and shares of common stock issuable upon exercise of the Warrants (the “Registration Statement”). The Private Placement was made pursuant to a securities purchase agreement by and among us and the investors.

     The exercise price for the Warrants is $5.33 per share. The Warrants are exercisable beginning on March 12, 2006 and expire on the later to occur of (i) the 180th trading day following the date the Registration Statement is declared effective by the Securities and Exchange Commission, and (ii) the 210th day following the closing date of the Private Placement. The number of shares issuable upon exercise of the Warrants is subject to adjustment for any stock dividends, stock splits or distributions by us, or upon any merger or consolidation or sale of assets of ours, tender or exchange offer for our common stock, or a reclassification of our common stock.

     We incurred issuance costs of $2,119,343, including a warrant to acquire 120,000 common shares, issued to the placement agent, having a fair value of $384,000. The exercise price of the placement warrants is $4.36 per share. The placement warrant are substantially the same as the Warrants sold except that it becomes exercisable on March 12, 2006 and expires on September 12, 2010.

     The net proceeds from the sale were allocated among the common stock and the 1,200,000 warrants sold. In the accompanying balance sheet the 1,200,000 warrants have been classified as liabilities at their issue date at their initial fair value of $804,000 and the residual proceeds from the offering have been attributed to the common stock. The 120,000 warrants issued to the placement agent were also reported as liabilities at their fair value of $384,000 on September 12, 2005. During the quarter ended October 31,

2005, the warrant liabilities were remeasured and the change in fair value of $118,800 has been reflected in the accompanying income statement.

     The proceeds from the Private Placement were used to repurchase outstanding warrants to purchase our common stock held by Mitchell A. Saltz and Robert L. Scott, who are directors of ours, and for general working capital. We also entered into an agreement with Messrs. Saltz, Scott, and Colton R. Melby, another director of ours, pursuant to which Messrs. Saltz, Scott, and Melby have agreed to sell to us, at our discretion, an aggregate of 1,200,000 shares of the Company’s common stock if requested by us, at a price per share of $5.33. Our right to purchase the shares terminates on the 10 ^th day following the expiration of the Warrants issued in the Private Placement.

     Under the terms of the securities purchase agreement by and among us and the investors in the Private Placement, we are required to pay penalties if we fail to meet our obligations to register the Shares and shares issuable upon exercise of the Warrants. Specifically, if any of the following events (each an “Event”) occurs, we will be required to pay cash as partial liquidated damages to the Private Placement investors: (i) if we fail to file a registration statement registering the Shares and shares issuable upon exercise of the Warrant or the such registration statement is not declared effective on or prior to the dates specified in the securities purchase agreement; (ii) if, with certain exceptions, an investor is not permitted sell registered securities under the registration statement for any reason for five or more trading days in any calendar quarter; (iii) if, with certain exceptions, our common stock is not listed or quoted, or is suspended from trading, on an eligible market for a period of 3 trading days in any calendar quarter; (iv) if we fail to deliver a certificate evidencing any securities to an investor within 3 days after delivery of such certificate is required or the exercise rights of the investor pursuant to the Warrants are otherwise suspended for any reason; or (v) we fail to have available a sufficient number of authorized but unissued and otherwise unreserved shares of our common stock available to issue shares upon any exercise of the Warrants. Therefore under Emerging Issues Task Force (“EITF”) Issue No. 00-19, “Accounting for Derivative Financial Stock”, we recorded the net value of the warrants at the date of issuance as a warrant liability on the balance sheet of $1,188,000 and included the change in fair value, $118,800, from the date of issuance to October 31, 2005 in general and administrative expenses, in accordance with EITF 00-19. The fair value of the warrants was $1,306,800 at October 31, 2005.

(12) Restatement to Correct Accounting for Certain Stock Awards under Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees,” and to Adopt Statement of Financial Accounting Standards No. 123(R), “Share-Based Payment” (Revised 2004):

     In June 2005, we determined that our previously reported for financial statements for 2002, 2003, 2004 and the first three quarters of fiscal 2005 required restatement to increase compensation expense for certain employee stock awards. We issued warrants to two former employees in May 2001, containing a cashless exercise feature, and as a result compensation expense should have been adjusted in subsequent periods through April 30, 2005 for increases or decreases in the quoted value of our stock. In addition, in fiscal 2004 and 2005, we should have recorded compensation expense resulting from the modification of certain vested stock options for terminating employees. For the year ended April 30, 2005, we decided to early adopt Statement of Financial Accounting Standards No. 123(R), “Share-Based Payment,” (Revised 2004), (SFAS 123(R)), using the modified retrospective application method. We filed a report on Form 8-K on July 1, 2005 describing the need to restate our previously issued financial statements to correct compensation expense and our decision to adopt FAS 123(R). The financial statements included in this Form 10-Q for the quarter and six months ended October 31, 2004 have been restated to correct compensation expense and to adopt SFAS 123(R).

     The pre-tax impact for the quarter ended October 31, 2004 on the statement of operations for these transactions under APB 25 was to decrease previously reported general and administrative expense by approximately $1,400,000. The impact of the adoption of SFAS 123(R) on the quarter ended October 31, 2004 on operating expenses, income before income taxes, income tax expense, net income, cash flow from operations, cash flow from financing activities, and basic and fully diluted earnings per share is disclosed below.

Quarter Ended October 31, 2004

						Restated For
						APB 25
						Accounting				Adoption
		As Previously				For Stock				of
		Reported				Awards				SFAS 123(R)
Statement of Operations:
General and administrative expense		$	4,799,717			$	4,899,717			$	4,901,362
Total operating expenses			7,998,087				8,098,087				8,099,732
Income from operations			4,390,745				4,290,745				4,289,100
Income before income taxes			3,564,846				3,464,846				3,463,201
Income tax expense			1,321,639				1,285,049				1,356,791
Net income			2,243,207				2,179,797				2,106,410
Basic earnings per share		$	0.07			$	0.07			$	0.07
Diluted earnings per share		$	0.07			$	0.06			$	0.06

Six Months Ended October 31, 2004

						Restated For
						APB 25
						Accounting				Adoption
		As Previously				For Stock				of
		Reported				Awards				SFAS 123(R)
Statement of Operations:
General and administrative expense		$	8,400,258			$	7,100,258			$	8,579,016
Total operating expenses			14,497,017				13,197,017				14,675,775
Income from operations			7,256,215				8,556,215				7,077,457
Income before income taxes			5,992,182				7,292,182				5,813,424
Income tax expense			2,256,329				2,732,559				2,240,015
Net income			3,735,853				4,559,623				3,573,409
Basic earnings per share		$	0.12			$	0.15			$	0.11
Diluted earnings per share		$	0.11			$	0.13			$	0.10
Statement of Cash Flows:
Net income			3,735,853				4,559,623				3,573,409
Deferred taxes			2,129,028				2,605,258				2,112,714
Stock option expense (income)			—				(1,300,000	)			210,303

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

     Please refer to the Overview found in the Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended April 30, 2005. This Overview sets forth key management objectives and key performance indicators used by management as well as key industry data tracked by management.

Second Quarter Fiscal 2006 Highlights

     Net product sales for the three months ended October 31, 2005 was $35.5 million, a $6.5 million, or 22.2% increase over net product sales of $29.1 million for the three months ended October 31, 2004. Firearms sales, our core business, increased for the quarter by $6.7 million, or 25.5%, compared with the three months ended October 31, 2004.

     Net income for the three months ended October 31, 2005 was $692,377, compared with $2,106,410 for the three months ended October 31, 2004. The quarter ended October 31, 2004 included approximately $4.1 million in insurance refunds and favorable balance sheet adjustments relative to an agreement reached with one of our insurance carriers in October 2004.

     During the quarter ended October 31, 2005, we sold 6,000,000 shares of our common stock and warrants to acquire 1,200,000 shares of our common stock in a private placement to nine investors for gross proceeds of $28,020,000. The proceeds from this securities sale were used to repurchase warrants, issued in May 2001, to two of our executives. The repurchased warrants were exercisable for 8,970,300 shares our common stock. At the time of repurchase, the warrants were held by two former officers of our company, who are members of our board of directors.

Restatement/SEC Inquiry

     In August 2003, we decided to amend various reports previously filed with the SEC to modify certain accounting matters related to our acquisition of Smith & Wesson Corp. We decided to restate our Form 10-KSB Report for the fiscal year ended April 30, 2002 as well as our Form 10-QSB Reports for the quarters ended July 31, 2001 and 2002, October 31, 2001 and 2002, and January 31, 2002 and 2003. The Form 10-KSB Report for the fiscal year ended April 30, 2003 was filed in December 2003 and included restated financial statements for fiscal 2002. The amended Form 10-QSB Reports for the July and October quarters were filed in January 2004, and the amended Form 10-QSB Reports for the January quarters were filed in March 2004. The SEC is conducting an informal inquiry regarding the circumstances surrounding the restatement. We are cooperating fully with the SEC in this inquiry. The inquiry is still ongoing.

     In June 2005, we determined that our previously reported financial statements for 2002, 2003, 2004 and the first three quarters of 2005 required restatement to increase compensation expense for certain employee stock awards. We issued warrants to two former employees in May 2001, containing a cashless exercise feature, and as a result compensation expense should have been adjusted in subsequent periods through April 30, 2005 for increases or decreases in the quoted value of our stock. In addition, in fiscal 2004 and 2005, we should have recorded compensation expense resulting from the modification of certain vested stock options for terminating employees. For the year ended April 30, 2005, we decided to early adopt Statement of Financial Accounting Standards No. 123(R), “Share-Based Payment,” (Revised 2004), (SFAS 123(R)), using the modified retrospective application method. We filed a report on Form 8-K on July 1, 2005 describing the need to restate our previously issued financial statements to correct compensation expense and our decision to adopt FAS 123(R). The financial statements included in this Form 10-Q for the quarter and six months ended October 31, 2004 have been restated to correct compensation expense and to adopt SFAS 123(R). The effect of this restatement is described in Note 12 to the consolidated financial statements.

Results of Operations

Net Product Sales

     The following table sets forth certain information relative to net product sales for the three months ended October 31, 2005 and 2004:

														%
		2005				2004				$ Change				Change
Revolvers		$	15,158,307			$	13,234,428			$	1,923,879				14.5	%
Pistols			9,637,726				6,247,940				3,389,786				54.3	%
Walther			3,904,203				3,777,916				126,287				3.3	%
Performance Center			2,372,944				2,160,709				212,235				9.8	%
Engraving			1,049,740				213,093				836,647				392.6	%
Other			1,063,563				814,752				248,811				30.5	%
Total Firearms			33,186,483				26,448,838				6,737,645				25.5	%
Handcuffs			1,122,412				1,138,997				(16,585	)			-1.5	%
Specialty Services			645,740				881,533				(235,793	)			-26.7	%
Other			582,332				608,671				(26,339	)			-4.3	%
Non-Firearms			2,350,484				2,629,201				(278,717	)			-10.6	%
Total		$	35,536,967			$	29,078,039			$	6,458,928				22.2	%

     We recorded net product sales of $35,536,967 for the three months ended October 31, 2005, an increase of $6,458,928, or 22.2%, over the three months ended October 31, 2004. Firearms sales increased by $6,737,645, or 25.5%, over the comparable quarter last year. Non-firearm sales for the three months ended October 31, 2005 declined by $278,717, or 10.6%, compared with the three months ended October 31, 2004 due primarily to lower specialty services sales, particularly in our forging business.

     Revolver sales increased by $1,923,879, or 14.5%, for the three months ended October 31, 2005 to $15,158,307, compared with the three months ended October 31, 2004. The increase resulted from a 14.1% increase in units sold as well as a continued shift to higher priced models. The large frame revolvers continue to generate significant interest, accounting for almost 20% of our unit volume. The Model 460 revolver began shipping late in the first quarter, and we completed filling the backlog of this new revolver in the quarter ended October 31, 2005. The revolver order backlog was at $5,998,780 at October 31, 2005.

     Pistol sales of $9,637,726 were $3,389,786, or 54.3% higher, for the three months ended October 31, 2005, compared with the three months ended October 31, 2004. The increase in pistol sales was primarily attributable to the large government contract for 12,144 Sigma pistols for the Afghanistan Border Patrol. The pistol order backlog was at $4,003,449 at October 31, 2005.

     We are the exclusive U.S. distributor of Walther firearms. Walther firearms sales increased by $126,287, or 3.3%, for the three months ended October 31, 2005, compared with the three months ended October 31, 2004. The increase in Walther sales was attributable to increased demand for the PPK pistol. Walther order backlog was at $622,167 at October 31, 2005.

     Performance Center sales increased by $212,235, or 9.8%, for the three months ended October 31, 2005 to $2,372,944, compared with the comparable period last year. Custom variations of the Model 460 were responsible for the increase in sales. The Performance Center had an order backlog of $1,371,030 at October 31, 2005.

     Engraving sales increased by $836,647, or 392.6%, for the three months ended October 31, 2005 as compared with the comparable period last year. This increase is a result of our increased emphasis on the marketing of the engraving services.

     The following table set forth certain information relative to net product sales for the six months ended October 31, 2005 and 2004 :

														%
		2005				2004				$ Change				Change
Revolvers		$	28,421,696			$	26,204,774			$	2,216,922				8.5	%
Pistols			19,087,875				11,856,467				7,231,408				61.0	%
Walther			7,283,380				7,642,721				(359,341	)			-4.7	%
Performance Center			4,020,433				4,404,776				(384,343	)			-8.7	%
Engraving			2,074,638				340,943				1,733,695				508.5	%
Other			1,636,555				1,308,390				328,165				25.1	%
Total Firearms			62,524,577				51,758,071				10,766,506				20.8	%
Handcuffs			2,240,799				2,091,558				149,241				7.1	%
Specialty Services			1,494,152				1,864,118				(369,966	)			-19.8	%
Other			1,127,162				1,133,167				(6,005	)			-0.5	%
Non-Firearms			4,862,113				5,088,843				(226,730	)			-4.5	%
Total		$	67,386,690			$	56,846,914			$	10,539,776				18.5	%

     Sales for the six months ended October 31, 2005 were $67,386,690, an increase of $10,539,776 or 18.5%, over the six months ended October 31, 2004. Firearms sales increased by $10,766,506, or 20.8%, over the comparable period last year. Non-firearm sales for the six months ended October 31, 2005 declined by $226,730, or 4.5%, compared with the six months ended October 31, 2004 due to lower Specialty Services sales.

     Revolver sales increased by $2,216,922, or 8.5%, for the six months ended October 31, 2005 to $28,421,696 compared with $26,204,774 for the six months ended October 31, 2004. Units sold increased by 8.8%, with the balance of the sale increase attributable to the introduction of the Model 460 revolver. We sold over 9,000 Model 460 revolvers in the six months ended October 31, 2005.

     Pistol sales of $19,087,875 were $7,231,408, or 61.0%, higher for the six months ended October 31, 2005 compared with the comparable period last year. The increase in pistol sales was primarily attributable to higher sales of our Sigma polymer pistol line. Sales of polymer pistols increased by 67.0% from approximately 21,000 units for the six months ended October 31, 2004 to approximately 47,500 units for the six months ended October 31, 2005. The Afghanistan military contract accounted for approximately 60.0% of the increase, with increased consumer demand responsible for the balance.

     Walther firearms sales declined by $359,341 for the six months ended October 31, 2005 due to lower sales of the P22 and P99 pistols. Performance Center sales decreased by $384,343, or 8.7%, for the six months ended October 31, 2005 to $4,020,433, compared with the comparable period last year. Lower sales of custom pistols were responsible for the decrease in sales.

     Engraving sales increased by $1,733,695, or 508.5%, for the three months ended October 31, 2005 as compared with the

comparable period last year. This increase is a result of our increase emphasis on the marketing of the engraving services.

     Non-firearms sales declined by $226,730, or 4.5%, for the six months ended October 31, 2005 as a result of lower Specialty Services revenue. Handcuff sales increased by $149,241, or 7.1%, over the six months ended October 31, 2004.

Licensing Revenue

     The following table sets forth certain information relative to licensing revenue for the three months ended October 31, 2005 and 2004:

														%
		2005				2004				$ Change				Change
Licensing Revenue		$	482,213			$	526,018				($43,805	)			-8.3	%

     Licensing revenue for the three months ended October 31, 2005 decreased by $43,805, or 8.3%, compared with the three months ended October 31, 2004. The decrease was attributable to revenue derived from a new licensee in the three months ended October 31, 2004.

     The following table sets forth certain information relative to licensing revenue for the six months ended October 31, 2005 and 2004:

														%
		2005				2004				$ Change				Change
Licensing Revenue		$	1,282,190			$	922,768			$	359,422				39.0	%

     Licensing revenue for the six months ended October 31, 2005 was $1,282,190, an increase of $359,422, or 39.0%, over the six months ended October 31, 2004. A first quarter FY2006 audit of an existing licensee revealed an underpayment in royalties for prior years totaling $350,000. The underpayment was recorded as revenue during the quarter ended July 31, 2005. In addition, a contract extension with another licensee in the quarter ended July 31, 2005 yielded an advance payment of $100,000.

Cost of Sales, Services, and Licensing and Gross Profit

     The following table sets forth certain information regarding cost of sales and services and gross profit for the three months ended October 31, 2005 and 2004:

														%
		2005				2004				$ Change				Change
Cost of sales and services		$	25,474,378			$	17,215,225			$	8,259,153				48.0	%
% sales and licensing revenue			70.7	%			58.2	%
Gross profit		$	10,544,802			$	12,388,832				($1,844,030	)			-14.9	%
% sales and licensing revenue			29.3	%			41.8	%

     Gross profit for the three months ended October 31, 2005 decreased by $1,844,030, or 14.9% from the three months ended October 31, 2004. Gross profit for the three months ended October 31, 2004 includes the $4.1 million favorable impact from an agreement reached with one of our insurance carriers. This included a $1.9 million refund from the insurance carrier as well as a $2.2 million favorable adjustment to our municipal litigation reserves as a result of the agreement. Excluding this transaction, gross profit from operations actually increased by $2.3 million for the quarter ended October 31, 2005 compared with the quarter ended October 31, 2004.

     The $6.5 million in increased sales for the quarter ended October 31, 2005 translated into $2.3 million in additional gross profit. We also realized $166,244 in labor savings from improved efficiency. Workers compensation expense for the quarter was $400,189 lower than the quarter ended October 31, 2004. Depreciation expense for the quarter increased by $351,044 compared with the quarter ended October 31, 2004. Utility costs for the quarter also increased by $207,917 over the comparable period last year.

     Gross profit, as a percentage of net product sales and licensing revenue, decreased from 41.8% for the three months October 31, 2004 to 29.3% for the three months ended October 31, 2005. The 41.8% gross profit percentage reflects the insurance agreement. Excluding the insurance impact, gross profit as a percentage of net product sales and licensing for the three months ended October 31, 2004 was 27.9%.

     The following table sets forth certain information regarding cost of sales and services and gross profit for the six months ended October 31, 2005 and 2004:

														%
		2005				2004				$ Change				Change
Cost of sales and services		$	48,525,189			$	36,016,450			$	12,508,739				34.7	%
% sales and licensing revenue			70.7	%			62.3	%
Gross profit		$	20,143,691			$	21,753,232				($1,609,541	)			-7.4	%
% sales and licensing revenue			29.3	%			37.7	%

     Gross profit for the six months ended October 31, 2005 decreased by $1,609,541, or 7.4%, from the six months ended October 31, 2004. The decrease in gross profit was attributable to a $2.2 million favorable adjustment in our municipal litigation reserves in the quarter ended October 31, 2004 as a result of a settlement reached with one of our insurance carriers. We also received a $1.9 million refund as part of the settlement, which was included in gross profit for the six months ended October 31, 2004. The $10.5 million in increased sales for the six months ended October 31, 2005 translated into approximately $3.8 million in additional gross profit, partially offsetting the impact of the one-time insurance benefit in the previous fiscal year. Depreciation expense for the six months ended October 31, 2005 increased by $684,417 to $1,382,022 as compared with $796,605 for the six months ended October 31, 2004. Utility costs increased by $340,532 for the six months ended October 31, 2005 compared with the six months ended October 31, 2004. Gross profit, as a percentage of net product sales and licensing revenue, decreased from 37.7% for the six months ended October 31, 2004 to 29.3% for the six months ended October 31, 2005. Gross profit for the six months ended October 31, 2004, as a percentage net product sales and licensing revenue, was 30.5%, excluding the insurance impact.

Operating Expenses

     The following table sets forth certain information regarding operating expenses for the three months ended October 31, 2005 and 2004: